obinutuzumab | Obinutuzumab: Uses, Dosage, Side Effects, Warnings

Keyword	CPC	PCC	Volume	Score	Length of keyword
obinutuzumab	1.31	0.3	7155	13	12

Keyword	CPC	PCC	Volume	Score
obinutuzumab	0.08	0.3	681	13
obinutuzumab package insert	0.11	1	7581	38
obinutuzumab venetoclax	1.56	0.3	4700	36
obinutuzumab side effects	0.33	1	9430	41
obinutuzumab vs rituximab	0.47	0.9	1366	22
obinutuzumab venetoclax protocol	1.5	0.6	1060	29
obinutuzumab moa	1.63	0.2	205	27
obinutuzumab mechanism of action	1.97	0.5	4255	99
obinutuzumab cll	1.41	0.5	1165	65
obinutuzumab cost	0.36	0.2	1550	35
obinutuzumab sle	1.88	0.2	8699	22
obinutuzumab spc	0.19	0.4	3541	28
obinutuzumab venetoclax relapsed cll	0.73	0.9	2865	99
obinutuzumab lupus	1.01	0.3	9139	56
obinutuzumabe	1.24	0.4	8547	46
obinutuzumab gazyva	0.27	0.6	4356	9
obinutuzumab bnf	1.29	0.9	805	64
obinutuzumab chpl	1.01	0.7	4972	83
obinutuzumab infusion	0.12	0.2	7115	52
obinutuzumab fachinformation	0.74	1	456	6
obinutuzumab glofitamab	1.51	0.9	1405	76
obinutuzumab j code	0.92	0.8	6984	29
obinutuzumab ficha tecnica	0.61	0.1	4164	52
obinutuzumab lupus nephritis	0.82	0.8	4593	47
obinutuzumab venetoclax cll	0.34	1	21	10

Search Results related to obinutuzumab on Search Engine

Obinutuzumab: Uses, Dosage, Side Effects, Warnings - Drugs.com
drugs.com

https://www.drugs.com/obinutuzumab.html

WEBApr 4, 2023 · Obinutuzumab (Gazyva) is a type of targeted chemotherapy drug for the treatment of certain blood cancers. It is a biological drug called a monoclonal antibody that targets and attaches to CD20, a protein found on the surface of B-cells.

DA: 55 PA: 47 MOZ Rank: 31

GAZYVA® (obinutuzumab) Treatment, Indications, Dosing & Safety
gazyva.com

https://www.gazyva.com/

WEBGAZYVA ® (obinutuzumab) is a prescription medicine used in combination with chemotherapy, followed by GAZYVA alone in those who responded, to treat stage II bulky, III, or IV follicular lymphoma (FL) in adults who have not had previous FL treatment.

DA: 47 PA: 11 MOZ Rank: 56

Obinutuzumab (Intravenous Route) Description and Brand …
mayoclinic.org

https://www.mayoclinic.org/drugs-supplements/obinutuzumab-intravenous-route/description/drg-20088520

WEBFeb 1, 2024 · Descriptions. Obinutuzumab injection is used together with other medicines (eg, chlorambucil) to treat chronic lymphocytic leukemia (CLL). Obinutuzumab injection is also used together with bendamustine to treat follicular lymphoma after other medicines (eg, rituximab) did not work well.

DA: 46 PA: 93 MOZ Rank: 32

Obinutuzumab - Wikipedia
wikipedia.org

https://en.wikipedia.org/wiki/Obinutuzumab

WEBMedical uses. Obinutuzumab is used in combination with chlorambucil as a first-line treatment for chronic lymphocytic leukemia. [5] [7] It is also used in combination with bendamustine followed by obinutuzumab monotherapy for the treatment of people with follicular lymphoma as a second line treatment to a regimen containing rituximab. [5] [8 ...

DA: 49 PA: 65 MOZ Rank: 50

Obinutuzumab - NCI - National Cancer Institute
cancer.gov

https://www.cancer.gov/about-cancer/treatment/drugs/obinutuzumab

WEBThis page contains brief information about obinutuzumab and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

DA: 91 PA: 30 MOZ Rank: 70

Gazyva: Side Effects, Dosage & Uses - Drugs.com
drugs.com

https://www.drugs.com/gazyva.html

WEBAug 23, 2023 · Gazyva is a monoclonal antibody that affects the actions of the body's immune system. Obinutuzumab strengthens your immune system to help your body fight against tumor cells. Gazyva is used in combination with another cancer medicine called chlorambucil to treat chronic lymphocytic leukemia.

DA: 60 PA: 48 MOZ Rank: 72

Obinutuzumab | FDA
fda.gov

https://www.fda.gov/drugs/resources-information-approved-drugs/obinutuzumab

WEBObinutuzumab. On February 26, 2016, the U. S. Food and Drug Administration approved obinutuzumab (Gazyva Injection, Genentech, Inc.) for use in combination with bendamustine followed by...

DA: 58 PA: 57 MOZ Rank: 25

Obinutuzumab: Uses, Interactions, Mechanism of Action
drugbank.com

https://go.drugbank.com/drugs/DB08935

WEBObinutuzumab is a humanized monoclonal antibody used as a combination treatment with chlorambucil to treat patients with untreated chronic lymphocytic leukemia. It was approved by the FDA in November 2013 and is marketed under the brand name Gazyva.

DA: 78 PA: 75 MOZ Rank: 6

Obinutuzumab (Gazyvaro) | Cancer information | Cancer …
cancerresearchuk.org

https://www.cancerresearchuk.org/about-cancer/treatment/drugs/obinutuzumab

WEBNov 21, 2023 · Obinutuzumab is a type of targeted cancer drug. It is a treatment for chronic lymphocytic leukaemia and follicular lymphoma. Find out about how you have it, possible side effects and other important information.

DA: 29 PA: 85 MOZ Rank: 73

Obinutuzumab Injection: MedlinePlus Drug Information
medlineplus.gov

https://medlineplus.gov/druginfo/meds/a614012.html

WEBObinutuzumab injection is used alone or in combination with other medication (s) to treat chronic lymphocytic leukemia (CLL; a type of cancer of the white blood cells) and to treat follicular non-Hodgkin's lymphoma (NHL; a slow-growing blood cancer). Obinutuzumab injection is in a class of medications called monoclonal antibodies.

DA: 8 PA: 91 MOZ Rank: 88